(Updated - April 26, 2024 8:17 AM EDT)

KeyBanc analyst Brett Fishbin raised the price target on ResMed (NYSE ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE